George S. Cembrowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
George S. Cembrowski has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
A. Fuezery
Department of Laboratory Medicine and Pathology, University of Alberta Hospital, Edmonton, AB, Canada
1 shared publicationAdam R. Cembrowski
University of Alberta, 116 St & 85 Ave, Edmonton, AB T6G 2R3, Canada
1 shared publicationD. Holmes
Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada
1 shared publicationD. Tran
University of Alberta, Edmonton, AB, Canada
1 shared publicationDavid V. Tran
University of Alberta Hospital, Edmonton, Alberta, Canada
1 shared publicationG. Clarke
University of Alberta, Edmonton, AB, Canada
1 shared publication
Latest Publications
- 1 December 2017
- Published by Elsevier in Clinical Biochemistry
- Vol. 50 (18) , 1164-1167
Low sensitivity of anion gap to detect clinically significant lactic acidosis in the emergency department
- 1 December 2017
- Published by Elsevier in Clinical Biochemistry
- Vol. 50 (18) , 1164-1167
Low sensitivity of anion gap to detect clinically significant lactic acidosis in the emergency department
- Open Access
- 1 November 2017
- Published by Elsevier in Clinical Biochemistry
- Vol. 50 (16-17) , 936-941
Impaired clinical utility of sequential patient GEM blood gas measurements associated with calibration schedule
- 1 November 2017
- Published by Elsevier in Clinical Biochemistry
- Vol. 50 (16-17) , 936-941
Open AccessImpaired clinical utility of sequential patient GEM blood gas measurements associated with calibration schedule
- Open Access
- 1 July 2016
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 62 (7) , 907-909
Demystifying Reference Sample Quality Control
One of the most frequent questions asked by the new clinical chemist is, “How do I set up the quality control for a particular analyzer?” Two new documents desc
- 1 July 2016
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 62 (7) , 907-909
Open AccessDemystifying Reference Sample Quality Control
One of the most frequent questions asked by the new clinical chemist is, “How do I set up the quality control for a particular analyzer?” Two new documents desc
- 19 December 2015
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 38 (2) , 111-118
The use of serial outpatient complete blood count (CBC) results to derive biologic variation: a new tool to gauge the acceptability of hematology testing
Summary: Introduction: Most estimates of biologic variation (sb) are based on periodically acquiring and storing specimens from reference subjects, followed by analysis within a tightly controlled analytic run. We demonstrate that reliable estimates of sb can be derived for virtually all constituents of the CBC from previously obtained paired patient results and summary QC data.Methods: A laboratory data repository provided all of the outpatient CBC results measured over 20.5 months at a large Canadian referral laboratory. These CBC measurements were taken on one of four Beckman Coulter LH analyzers. A total of 1852 different patients had CBCs repeated at least twice within 84 h. We tabulated the pairs of intrapatient constituents that were separated by 0–6, 6–12, 12–18,… 72–78, and 78–84 h. The standard deviations of duplicates (SDD) of the paired data were then regressed against time. The y‐intercept represents the sum of sb and short‐term analytic variation (sa): y0 =(s2a +s2b)1/2. The short‐term imprecision was determined from normal range Coulter quality control specimens.Results: Patient sb for hematocrit, MCH, absolute monocytes, and absolute neutrophils are extremely close to those determined by biologic variation experiments using healthy volunteers. Most of the other estimates of sb tended to be slightly lower than literature estimates.Conclusions: We describe a novel approach to deriving sb. The ratio of the sb to sa (a measure of sigma) indicates that the Beckman Coulter LH is extremely suitable for CBC monitoring of outpatients as well as for inpatients, whose sb is generally higher.
- 19 December 2015
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 38 (2) , 111-118
The use of serial outpatient complete blood count (CBC) results to derive biologic variation: a new tool to gauge the acceptability of hematology testing
Summary: Introduction: Most estimates of biologic variation (sb) are based on periodically acquiring and storing specimens from reference subjects, followed by analysis within a tightly controlled analytic run. We demonstrate that reliable estimates of sb can be derived for virtually all constituents of the CBC from previously obtained paired patient results and summary QC data.Methods: A laboratory data repository provided all of the outpatient CBC results measured over 20.5 months at a large Canadian referral laboratory. These CBC measurements were taken on one of four Beckman Coulter LH analyzers. A total of 1852 different patients had CBCs repeated at least twice within 84 h. We tabulated the pairs of intrapatient constituents that were separated by 0–6, 6–12, 12–18,… 72–78, and 78–84 h. The standard deviations of duplicates (SDD) of the paired data were then regressed against time. The y‐intercept represents the sum of sb and short‐term analytic variation (sa): y0 =(s2a +s2b)1/2. The short‐term imprecision was determined from normal range Coulter quality control specimens.Results: Patient sb for hematocrit, MCH, absolute monocytes, and absolute neutrophils are extremely close to those determined by biologic variation experiments using healthy volunteers. Most of the other estimates of sb tended to be slightly lower than literature estimates.Conclusions: We describe a novel approach to deriving sb. The ratio of the sb to sa (a measure of sigma) indicates that the Beckman Coulter LH is extremely suitable for CBC monitoring of outpatients as well as for inpatients, whose sb is generally higher.
- Open Access
- 18 October 2015
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 10 (1) , 72-75
The Glucose Measurement Industry and Hemoglobin A1c
The MyStar Extra self-monitoring blood glucose (SMBG) system provides moving estimates of the patient’s hemoglobin A1c (HbA1c). There is a treasure trove of highly accurate glucose data available from highly accurate SMBG, CGM and FGM along with highly accurate HPLC HbA1c. If Nathan’s criteria are used to select subjects whose glucoses can be correlated to the HbA1c, then algorithms can be developed for robustly transforming glucose into HbA1c. These algorithms can then be implemented in any SMBG or with the CGM and FGM software. This calculated HbA1c would even be accurate with Nathan’s excluded population thus reducing the use of fructosamine and glycated protein. Finally, the developer of these new algorithms is advised to use a specific approach for testing her algorithm.
- 18 October 2015
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 10 (1) , 72-75
Open AccessThe Glucose Measurement Industry and Hemoglobin A1c
The MyStar Extra self-monitoring blood glucose (SMBG) system provides moving estimates of the patient’s hemoglobin A1c (HbA1c). There is a treasure trove of highly accurate glucose data available from highly accurate SMBG, CGM and FGM along with highly accurate HPLC HbA1c. If Nathan’s criteria are used to select subjects whose glucoses can be correlated to the HbA1c, then algorithms can be developed for robustly transforming glucose into HbA1c. These algorithms can then be implemented in any SMBG or with the CGM and FGM software. This calculated HbA1c would even be accurate with Nathan’s excluded population thus reducing the use of fructosamine and glycated protein. Finally, the developer of these new algorithms is advised to use a specific approach for testing her algorithm.
- Open Access
- 1 September 2015
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 144 (3) , 423-426
Limiting the Testing of AST
Objectives. Annually, millions of pairs of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) tests are ordered. These enzymes are hig
- 1 September 2015
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 144 (3) , 423-426
Open AccessLimiting the Testing of AST
Objectives. Annually, millions of pairs of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) tests are ordered. These enzymes are hig
- 1 March 2015
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 35 (1) , 59-71
Quality Control of Automated Cell Counters
- 1 March 2015
- Published by Elsevier in Clinics In Laboratory Medicine
- Vol. 35 (1) , 59-71
Quality Control of Automated Cell Counters
- Open Access
- 1 January 2013
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 7 (1) , 190-192
Within-Individual Hematocrit Variations and Self-Monitoring of Blood Glucose
Many self-monitoring of blood glucose (SMBG) systems have generated artefactually increased glucose results in low-hematocrit patients (e.g., intensive care unit and renal failure patients); conversely, these devices could produce artefactually decreased glucose results in high-hematocrit patients (e.g., neonates). The introduction of hematocrit-independent SMBG systems permits more accurate testing in anemic or polycythemic individuals. In this issue of Journal of Diabetes Science and Technology, Ramljak and coauthors have created glucose bias graphs for 19 common SMBG devices and declared certain systems to be optimally accurate because of insensitivity to hematocrit variation over a broad hematocrit range. Luckily, the average within-individual variation of hematocrit is low (between 2.9 and 3.3%). As such, a larger spectrum of SMBG devices can be regarded as optimally hematocrit independent.
- 1 January 2013
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 7 (1) , 190-192
Open AccessWithin-Individual Hematocrit Variations and Self-Monitoring of Blood Glucose
Many self-monitoring of blood glucose (SMBG) systems have generated artefactually increased glucose results in low-hematocrit patients (e.g., intensive care unit and renal failure patients); conversely, these devices could produce artefactually decreased glucose results in high-hematocrit patients (e.g., neonates). The introduction of hematocrit-independent SMBG systems permits more accurate testing in anemic or polycythemic individuals. In this issue of Journal of Diabetes Science and Technology, Ramljak and coauthors have created glucose bias graphs for 19 common SMBG devices and declared certain systems to be optimally accurate because of insensitivity to hematocrit variation over a broad hematocrit range. Luckily, the average within-individual variation of hematocrit is low (between 2.9 and 3.3%). As such, a larger spectrum of SMBG devices can be regarded as optimally hematocrit independent.
- 27 July 2010
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 48 (10) , 1447-1454
The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing
Background: Most estimates of biologic variation (sb) are based on periodically acquiring and storing specimens, followed by analysis within a single analytic run. We demonstrate for many intensive care unit (ICU) tests, only patient results need be statistically analyzed to provide reliable estimates of sb. Methods: Over 11 months, approximately 28,000 blood gas measurements (including electrolyte panels and glucose) were performed on one of two Radiometer ABL800 FLEX analyzers (Radiometer, Copenhagen, Denmark) from 1676 ICU patients. We tabulated the measurements of paired intra-patient blood samples drawn within 24 h of each other. After removal of outliers, we calculated the standard deviations of duplicates (SDD) of the intra-patient pairs grouped in 2-h intervals: 0–2 h, 2–4 h, 4–6 h, … 20–22 h and 22–24 h. The SDDs were then regressed against the time intervals of 2–14 h; extrapolation to zero time represents the sum of sb and short-term analytic variation (sa). Results: Substitution of experimentally derived analytic error permitted the calculation of coefficient of variation (biologic) (CVb) (100 sb/mean): pH, 0.3%; pCO2, 5.7%; pO2, 13%; Na+, 0.6%; K+, 4.8%; Cl–, 0.8%; HCO3 –, 3.2%; iCa++, 2.4%; and glucose, 10.3%. The CVb of the electrolytes very closely matches the lowest estimates obtained in the usual manner. Conclusions: Derivation of the ratio of biologic to analytic variation indicates that the ABL800 is extremely suitable for ICU testing. This analysis should be extended to other point of care instrument systems. Clin Chem Lab Med 2010;48:1447–54.
- 27 July 2010
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 48 (10) , 1447-1454
The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing
Background: Most estimates of biologic variation (sb) are based on periodically acquiring and storing specimens, followed by analysis within a single analytic run. We demonstrate for many intensive care unit (ICU) tests, only patient results need be statistically analyzed to provide reliable estimates of sb. Methods: Over 11 months, approximately 28,000 blood gas measurements (including electrolyte panels and glucose) were performed on one of two Radiometer ABL800 FLEX analyzers (Radiometer, Copenhagen, Denmark) from 1676 ICU patients. We tabulated the measurements of paired intra-patient blood samples drawn within 24 h of each other. After removal of outliers, we calculated the standard deviations of duplicates (SDD) of the intra-patient pairs grouped in 2-h intervals: 0–2 h, 2–4 h, 4–6 h, … 20–22 h and 22–24 h. The SDDs were then regressed against the time intervals of 2–14 h; extrapolation to zero time represents the sum of sb and short-term analytic variation (sa). Results: Substitution of experimentally derived analytic error permitted the calculation of coefficient of variation (biologic) (CVb) (100 sb/mean): pH, 0.3%; pCO2, 5.7%; pO2, 13%; Na+, 0.6%; K+, 4.8%; Cl–, 0.8%; HCO3 –, 3.2%; iCa++, 2.4%; and glucose, 10.3%. The CVb of the electrolytes very closely matches the lowest estimates obtained in the usual manner. Conclusions: Derivation of the ratio of biologic to analytic variation indicates that the ABL800 is extremely suitable for ICU testing. This analysis should be extended to other point of care instrument systems. Clin Chem Lab Med 2010;48:1447–54.